Table 7.
In-feed antimicrobial use by indication and class of medically important antimicrobial drug (AMD)a, organized by category of importance to human medicineb and expressed in total number of animal daily doses (nADD).
| Indication | ||||||
|---|---|---|---|---|---|---|
| Histophilosis | Liver abscesses | Other | Total | |||
| AMD Class | AMD | nADD No. (% of use of specific AMD class, % of use for specified indication) | ||||
| II | MAC | Tylosin | 0 (0, 0) | 1,903,454 (100.0, 11.1) | 0 (0, 0) | 1,903,454 |
| III | TET | Chlortetracycline | 11,531,483 (43.3, 100.0) | 15,052,190 (56.5, 88.1) | 37,815 (0.1, 49.6) | 26,621,488 |
| Oxytetracycline | 0 (0, 0) | 127,187 (76.8, 0.7) | 38,468 (23.2, 50.4) | 165,655 | ||
| Total | 11,531,483 | 17,082,831 | 76,283 | 28,690,597 | ||
The nADD are presented in the left part of the cell, and the % of the use of the specific AMD class and the % of use for the specified indication are presented in the right part of the cell separated by a comma. Percentages of use may not add to 100% due to rounding.
a
MAC, macrolides; TET, tetracyclines.
b
Roman numerals I to III designate categories of importance to human medicine as designated by the Canadian Veterinary Drugs Directorate.